Dr. Ankeet Bhatt and Dr. C. Michael Gibson Discuss: Electronic Nudges to Increase Influenza Vaccination Among Patients With History of Myocardial Infarction: Insights From 3 Randomized Clinical Trials Enrolling >2 Million Patients (NUDGE-FLU) November 17, 2024 Disclosures: TBD
Dr. Dorairaj Prabhakaran and Dr. C. Michael Gibson Discuss: TOPSPIN- A Three-Arm Randomized Trial for Treatment Optimization of Blood Pressure With Single-Pill Combinations In India November 17, 2024 Disclosures: TBD
Dr. Rohan Khera and Dr. C. Michael Gibson Discuss: PanEcho: Complete AI-enabled Echocardiography Interpretation With Multitask Deep Learning November 16, 2024 Disclosures: TBD
Dr. Nobuyuki Kagiyama and Dr. C. Michael Gibson Discuss: Artificial Intelligence-Based Automated ECHOcardiographic Measurements and the Workflow of Sonographers (AI-ECHO): Randomized Crossover Trial November 16, 2024 Disclosures: TBD
Dr. Liviu Klein and Dr. C. Michael Gibson Discuss: Novel AI to Assess Intracardiac Filling Pressure: The Noninvasive SEISMocardiogram in Cardiovascular Monitoring for Heart Failure I (SEISMIC-HF I) Study November 16, 2024 Disclosures TBD
Dr. Milton Packer and Dr. C. Michael Gibson Discuss: Tirzepatide for Patients With Heart Failure With Preserved Ejection Fraction and Obesity: the SUMMIT Trial November 16, 2024 Disclosures: TBD
Stephan Baldus and Dr. C Michael Gibson Discuss: MATTERHORN: Atrial MR SubgroupTranscatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial October 30, 2024 Disclosures: TBD
Firas Zahr and Dr. C Michael Gibson Discuss: CLASP IID 2 YearRCT and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation October 30, 2024 Disclosures: TBD
Olivier F Bertrand and Dr. C Michael Gibson Discuss: TARGET IVInternational Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System October 30, 2024 Disclosures: TBD
Birgitte Krogsgaard Andersen and Niels Ramsing Holm and Dr. C Michael Gibson Discuss: FAVOR III EuropeQuantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization October 30, 2024 Disclosures: TBD
